Phase III study to evaluate the efficacy of a novel antimycotic vaginal pessary combination (containing Benzydamine HCl 6 mg and Econazole nitrate 150 mg) in the Treatment of uncomplicated vulvovaginal candidosis (VVC) [BEtreat study]
Latest Information Update: 26 Sep 2018
At a glance
- Drugs Benzydamine/econazole (Primary)
- Indications Vulvovaginal candidiasis
- Focus Registrational; Therapeutic Use
- Acronyms BEtreat study
- Sponsors Angelini Pharmaceuticals
- 26 Sep 2018 The trial has been completed in Bulgaria (End Date; 2018-04-02)
- 23 Feb 2018 New trial record